טוען...
Safety of valproic acid in patients with chronic obstructive pulmonary disease: a population-based cohort study
PURPOSE: Valproic acid is an anticonvulsant that also inhibits histone deacetylase (HDAC), a property that could worsen pulmonary function in patients with chronic obstructive pulmonary disease (COPD). The clinical significance of this property is unknown. We therefore compared the risk of COPD exac...
שמור ב:
| הוצא לאור ב: | Pharmacoepidemiol Drug Saf |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley & Sons, Ltd
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4497617/ https://ncbi.nlm.nih.gov/pubmed/25656984 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pds.3761 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|